Back
Bellevue Life Sciences Acquisition Stock Predictions
Sponsored
BLAC
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
32
BLAC
Bellevue Life Sciences Acquisition
Last Price:
10.91
Seasonality Move:
0.77%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Bellevue Life Sciences Acquisition Stock Forecast
-
Is Bellevue Life Sciences Acquisition Stock Undervalued?
The current Bellevue Life Sciences Acquisition [BLAC] share price is $10.89. The Score for BLAC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal. - BLAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Bellevue Life Sciences Acquisition Stock Go Up Next Year?
Data Unavailable
Bellevue Life Sciences Acquisition Stock Rating
Data Unavailable
Bellevue Life Sciences Acquisition Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
bellevuespac.com
52-Week Data
52-Week High:
11.60
52-Week Low:
10.39
Prediction Charts
Market Cap:
44.01M
Price in USD:
10.89
Volume:
0
Beta:
-0.04
Technical Analysis
SMA50:
10.84
SMA100:
10.80
SMA200:
10.70
52-Wk Change:
4.81%
Stock Predictions
-
Is Bellevue Life Sciences Acquisition stock public?
Yes, Bellevue Life Sciences Acquisition is a publicly traded company. -
What is the Bellevue Life Sciences Acquisition stock quote today?
The Bellevue Life Sciences Acquisition stock price is 10.89 USD today. -
How to buy Bellevue Life Sciences Acquisition stock online?
You can buy Bellevue Life Sciences Acquisition shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-30 | 10.80 | 10.82 | 10.82 | 10.80 |
Sep-3 | 10.82 | 10.82 | 10.82 | 10.82 |
Sep-4 | 10.83 | 10.83 | 10.83 | 10.83 |
Sep-5 | 10.83 | 10.83 | 10.83 | 10.83 |
Sep-6 | 10.83 | 10.83 | 10.83 | 10.83 |
Sep-9 | 10.83 | 10.83 | 10.83 | 10.83 |
Sep-10 | 10.83 | 10.83 | 10.83 | 10.83 |
Sep-11 | 10.83 | 10.83 | 10.83 | 10.83 |
Sep-12 | 10.91 | 10.91 | 10.91 | 10.91 |
Sep-13 | 10.91 | 10.91 | 10.91 | 10.91 |
Sep-16 | 10.91 | 10.91 | 10.91 | 10.91 |
Sep-17 | 10.89 | 10.89 | 10.89 | 10.89 |
Sep-18 | 10.89 | 10.89 | 10.89 | 10.89 |
Sep-19 | 10.89 | 10.89 | 10.89 | 10.89 |
Bellevue Life Sciences Acquisition Earnings
Data Unavailable
Bellevue Life Sciences Acquisition Forecast Revenue Growth
Data Unavailable
* Bellevue Life Sciences Acquisition stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.